Partnership to Improve Patient Care

  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • Blog
    • PIPC Patients' Blog
    • Chairman's Corner
    • PIPC Weekly Update
    • The Data Mine
  • Newsroom
    • PIPC in the News
    • Press Releases
    • Open Letter: We Deserve a Voice
  • Events
    • PIPC Forum 2022
    • Discrimination & Health Care
    • C & GT Webinar
    • ICER COVID Webinar
    • Value Our Health Briefing
    • QALY Briefing
    • QALY Panel
    • Past Webinars >
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • Blog
    • PIPC Patients' Blog
    • Chairman's Corner
    • PIPC Weekly Update
    • The Data Mine
  • Newsroom
    • PIPC in the News
    • Press Releases
    • Open Letter: We Deserve a Voice
  • Events
    • PIPC Forum 2022
    • Discrimination & Health Care
    • C & GT Webinar
    • ICER COVID Webinar
    • Value Our Health Briefing
    • QALY Briefing
    • QALY Panel
    • Past Webinars >
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010

The PIPC Blog

PIPC Weekly Update - Feburary 9, 2015

2/9/2015

 
In This Week's Issue:
1. Inside Health Policy: PCORI Announces Funding To Compare Hep C Rx, Diagnostics, click hereto view the full article (subscription required).
2. PCORI Blogs: Funding, Heart Disease, Subject Protection, Missing Data, see below for details.
3. Brookings: How Hepatitis C is Shining a Light on Critical Gaps in Payment Reform, click here to view the full article.
4. Boston Globe: Portal Promotes Patient-Centered Multiple Sclerosis Research, click here to view the full article.
5. Brookings: The Significance of President Obama's Precision Medicine Initiative, click here to view the full article.
6. CEA: New Paper: Medicare Is Scrutinizing Evidence More Tightly for National Coverage Determinations, click here to view the full post.
7. Medical Journal Articles, see below for details.
8. AHRQ Effective Program Updates, see below for details.
1. Inside Health Policy: PCORI Announces Funding To Compare Hep C Rx, Diagnostics
​

On the heels of PCORI’s announcement about Hep C funding, Inside Health Policy wrote, “A day after Gilead Sciences executives projected larger than expected discounts on hepatitis C medications, Obamacare's comparative-effectiveness research panel on Wednesday (Feb. 4) offered $50 million to compare diagnostics and drugs for hepatitis C, according to a release from the Patient-Centered Outcomes Research Institute.[…]The hepatitis C funding is part of $138 million worth of research grants. The other $88 million funds a range of projects, $12 million of which is for rare diseases research. […][Paul Carter, Gilead's executive vice president] said pharmacy benefit managers are lifting restrictions on the drugs in return for rebates, and he even expects professional societies to change guidelines that call for only giving the drugs to the sickest patients. However, the rebates do not always mean that everyone infected with the virus gets the drugs, and patient advocates are still up in arms over restrictions.” Click here to view the full article (subscription required).

2. PCORI Blogs: Funding, Heart Disease, Subject Protection, Missing Data

What's New in Our Spring 2015 Funding Announcements?
Kara Odom Walker, Deputy Chief Science Officer, Tsahai Tafari, Associate Director of Science, and James Hulbert, Pre-Award Contracts Manager, announced new funding for the spring at PCORI last week, “PCORI is especially interested in the investigation of strategies that address care for patients with life-threatening or chronically debilitating rare diseases. These illnesses are of such low prevalence—defined as conditions that affect fewer than 200,000 people in the United States (i.e., less than 1 in 1,500 persons)—that special efforts, such as combining data across large populations, may be needed to address them.” Click here to view the full announcement.

Research Aims to Continue Reducing Toll of Heart Disease
Early last week, Dr. Diane E. Bild, Senior Program Officer for Science commented on the PCORI Blog, “PCORI's investment in its national data research network, PCORnet, is designed to support studies that will address important health challenges, including cardiovascular disease. The Health eHeart Alliance, one of the Patient-Powered Research Networks funded by PCORnet, supports studies that leverage big data and are aimed at heart disease prevention and management.” Click here to view the full post. 

Addressing Protection of Human Subjects in PCORI Applications and Merit Review
Cary Scheiderer, Merit Review Officer, Marina Broitman, Senior Merit Review Officer, and Tsahai Tafari, Associate Director of Science said in a PCIRO Blog post last week, “Research Integration and Evaluation At PCORI, we are always working to improve the way we do our work. As part of that work, we are now providing additional guidance and resources or applicants and reviewers to ensure that applications for our research funding and review of applications appropriately address the protection of human subjects.”  Click here to view the full post.

Now Accepting Letters of Intent for Latest Funding Cycle, including Hepatitis C Announcement 
Specifically citing funding grants for Hep C, Last week PCORI announced, “We issued six new PCORI Funding Announcements (PFAs) today. Five offer up to $88 million in support for a range of patient-centered comparative effectiveness research (CER) proposals under our national research priorities, with a pool of up to $12 million set aside for rare disease-focused studies. We also issued a new PFA targeting hepatitis C virus (HCV) infection, offering up to $50 million for up to four studies of key research questions in HCV diagnosis and treatment. Required Letters of Intent (LOIs) are due by 5 p.m. ET Friday, March 6. Find out more on the Funding Opportunities page on our website.”  Clickhere to view the announcement.  

3. Brookings: How Hepatitis C is Shining a Light on Critical Gaps in Payment Reform
Also commenting last week on Hep C, Kavita Patel, Morgan H. Romine and Gregory W. Daniel, write for The Brookings Institution, “In virtually all other aspects of health care, payment and delivery reforms are achieving a palpable shift away from volume and intensity toward patient-centered, higher value care...In this blog post, we consider alternative payment policies that could help to ensure that – despite their potentially high cost – breakthrough treatments are consistently delivering value to patients and that the health care system is addressing inefficiencies in the delivery and total costs of care.” Click here to view the full article.

4. Boston Globe: Portal Promotes Patient-Centered Multiple Sclerosis Research
Robert Weisman of The Boston Globe wrote, “[PCORI] last year issued $100 million in grants to health care providers and patient networks to get patients more involved in medical research and to promote studies that compare the effectiveness of various drugs for individual patients...The grants are part of a broader shift in medicine to customize the diagnosis and treatment of each patient on diseases from cancers to cystic fibrosis to multiple sclerosis. Having large databases of patients' records and therapies is critical to that effort.” Click here to view the full article.

5. Brookings: The Significance of President Obama's Precision Medicine Initiative
Additionally from The Brookings Institution, Gregory W. Daniel and Morgan Romine comment, “Traditional drug development programs have relied on a ‘one-size-fits-all’ approach, which tests drugs for specific therapeutic areas and uses a representative sample of patients with that disease. The promise of increasingly-targeted, precision medicine is in moving beyond that approach by using available science to deliver the most effective treatment possible, while also minimizing the potential for patients to receive unnecessary treatments that do not benefit them.” Click here to view the full article.

6. CEA: New Paper: Medicare Is Scrutinizing Evidence More Tightly for National Coverage Determinations
Writing for The CEA Registry Blog, James D. Chambers commented recently, “We found that when holding constant the level of supporting evidence, more recent coverage determinations (from mid-March 2008 through August 2012) were approximately twenty times less likely to be positive than earlier coverage determinations (from February 1999 through January 2002).  In other words, the evidentiary bar for medical intervention coverage under Medicare national coverage determinations became higher between 1999 and 2012.” Click here to view the full post.

7. Medical Journal Articles
Caring for Patients with Kidney Disease: Shifting the Paradigm from Evidence-Based Medicine to Patient-Centered Care: Click here to view.
Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, Paclitaxel, Trabectedin and Gemcitabine for Advanced Recurrent or Refractory Ovarian Cancer: A Systematic Review and Economic Evaluation: Click here to view. 
Comparative Effectiveness of Cefazolin Versus Cloxacillin as Definitive Antibiotic Therapy for MSSA Bacteraemia: Results from a Large Multicentre Cohort Study: Click here to view. 
Building Efficient Comparative Effectiveness Trials Through Adaptive Designs, Utility Functions, and Accrual Rate Optimization: Finding the Sweet Spot: Click here to view.
The Promise Of Biomedical Innovation: Click here to view.
Improving Pharmaceutical Innovation By Building A More Comprehensive Database On Drug Development And Use: Click here to view. 
Medicare Is Scrutinizing Evidence More Tightly For National Coverage Determinations: Click here to view. 
Evaluating Possible Confounding by Prescriber in Comparative Effectiveness Research: Click here to view.

8. AHRQ Effective Program Updates
Management and Outcomes of Binge-Eating Disorder (BED): click here to comment by February 25, 2015
Diagnosis of Celiac Disease: click here to comment by February 25, 2015
Strategies Used by Adults to Reduce Their Prescription Drug Costs: United States, 2013: Click here to view.
Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: Click here to review comments.  
Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma: Click here to review comments. 
The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain: Click here to review comments.
EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews: Click here to view the white paper.

Comments are closed.

    Topics

    All
    Alternative Payment Models
    Chairman's Corner
    Patient Centered Research
    PIPC In The News
    PIPC Patient Blog
    PIPC Weekly Update
    Press Releases
    The Data Mine
    Value Frameworks

    Archives

    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    April 2013
    March 2013
    December 2012
    November 2012
    February 2012
    September 2011
    August 2011
    July 2011
    May 2011
    March 2011
    November 2010
    October 2010
    September 2010
    August 2010
    April 2010
    March 2010
    February 2010
    December 2009
    September 2009
    July 2009
    June 2009
    May 2009
    February 2009
    January 2009
    December 2008

About PIPC
The Issues
Resources
Blog
In the News
Press Releases
Contact Us
100 M Street, SE – Ste. 750
Washington, DC 20003